Matthew Glimm

Mr. Matthew Glimm

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
HWHope D. Welhaven
Hope D. Welhaven
AWAvery H. Welfley
Avery H. Welfley
PBPriyanka Brahmachary
Priyanka Brahmachary
ABAnnika Rose Bergstrom
Annika Rose Bergstrom
EHEden Houske
Eden Houske
RJRonald K June
Ronald K June
Osteoarthritis (OA) is a chronic joint disease with heterogenous metabolic pathology. To gain insight into OA-related metabolism, metabolite extracts from healthy (n = 11) and end-stage osteoarthritic cartilage (n = 35) were analyzed using liquid chromatography–mass spectrometry metabolomic profiling. Specific metabolites and metabolic pathways, including lipid and amino acid pathways, were differentially regulated in osteoarthritis-derived and healthy cartilage. The detected alterations in amino acids and lipids highlighted key differences in bioenergetic resources, matrix homeostasis, and mitochondrial alterations in OA-derived cartilage compared to healthy cartilage. Moreover, the metabolomic profiles of osteoarthritic cartilage separated into four distinct endotypes, highlighting the heterogenous nature of OA metabolism and the diverse landscape within the joint in patients. The results of this study demonstrate that human cartilage has distinct metabolomic profiles in healthy and end-stage OA patients. By taking a comprehensive approach to assess metabolic differences between healthy and osteoarthritic cartilage and within osteoarthritic cartilage alone, several metabolic pathways with distinct regulation patterns were detected. Additional investigation may lead to the identification of metabolites that may serve as valuable indicators of disease status or potential therapeutic targets.

1 June 2023 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
EHEden A. Houske
Eden A. Houske
MGMatthew Glimm
Matthew Glimm
ABAnnika Rose Bergstrom
Annika Rose Bergstrom
SSSally K. Slipher
Sally K. Slipher
HWHope D. Welhaven
Hope D. Welhaven
AHAlyssa K. Hahn
Alyssa K. Hahn
To our knowledge, this study is the first to generate urinary global metabolomic profiles from individuals with early-stage ADPKD with preserved renal function for biomarker discovery. The exploratory dataset reveals metabolic pathway alterations that may be responsible for early cystogenesis and rapid disease progression and may be potential therapeutic targets and pathway sources for candidate biomarkers. From these results, we generated a panel of candidate diagnostic and prognostic biomarkers of early-stage ADPKD for future validation.